Overview
Oxytocin Bolus Versus Infusion in Elective Cesarean Section"
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2023-12-15
2023-12-15
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Bolus administration of oxytocin is superior to infusion in time to achieving adequate uterine tone.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Stony Brook UniversityTreatments:
Oxytocin
Criteria
Inclusion Criteria:- Parturients between the ages of 18 to 45 with singleton pregnancies
- Undergoing elective cesarean section under spinal anesthesia
- American Society of Anesthesia (ASA) physical status class I or II
- Patients must be able to provide written informed consent
Exclusion Criteria:
- Parturients in labor or ruptured membranes
- Multiple gestation
- Risk factors predisposing to uterine atony (history of placenta previa, preeclampsia,
diabetes mellitus macrosomia, hydramnios, bleeding diathesis, uterine fibroids)
- History of uterine atony or postpartum hemorrhage
- History of inherited or acquired coagulation disorders, thrombocytopenia (platelet
count <100), or anemia (hemoglobin < 8)
- History of allergy to oxytocin
- Patients not alert and orientated to person, place, and date. Patient must have, in
the investigator's opinion, the physical and mental capacity to answer survey
questions